Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS).
about
Hypoxia: The Force that Drives Chronic Kidney DiseaseThe impact of obstructive sleep apnea on chronic kidney disease.Sleep Related Breathing Disorders and Inflammation - The Missing Link? A Cohort Study Evaluating the Interaction of Inflammation and Sleep Related Breathing Disorders and Effects of Treatment.Potential role of adult stem cells in obstructive sleep apneaObstructive sleep apnoea as a risk factor for atherosclerosis - implication for preventive and personalised treatment.Inflammation induced by increased frequency of intermittent hypoxia is attenuated by tempol administrationCardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndromeObstructive sleep apnoea and cardiovascular complications: perception versus knowledge.Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis.The role inflammatory response genes in obstructive sleep apnea syndrome: a review.Obstructive sleep apnea increases the risk of cardiac events after percutaneous coronary intervention: a meta-analysis of prospective cohort studies.Cerebrovascular reactivity and neurovascular coupling in patients with obstructive sleep apnea.Low serum copeptin levels in patients with obstructive sleep apnea.Toll-like receptor activity in patients with obstructive sleep apnea.Serum levels of gamma-glutamyl transferase are associated with cardiovascular disease in obstructive sleep apnea syndrome.Analysis of systemic and airway inflammation in obstructive sleep apnea.Evaluation of the association between sleep apnea and polyunsaturated fatty acids profiles in patients after percutaneous coronary intervention.Effects of nondipping pattern on systemic inflammation in obstructive sleep apnea.Lymphocytes from intermittent hypoxia-exposed rats increase the apoptotic signals in endothelial cells via oxidative and inflammatory injury in vitro.Effect of chronic continual- and intermittent hypoxia-induced systemic inflammation on the cardiovascular system in rats.Increased plasma soluble tumor necrosis factor receptor-1 and myeloperoxidase activity in patients with obstructive sleep apnea syndrome.Does CPAP therapy alter urinary albumin level in adult patients with moderate to severe obstructive sleep apnea syndrome?Heart rate recovery post 6-minute walking test in obstructive sleep apnea: cycle ergometry versus 6-minute walking test in OSA patients.The prevalence and associated risk factors of sleep disorder-related symptoms in pregnant women in China.Influence of CPAP treatment on airway and systemic inflammation in OSAS patients.Oxidative stress in patients with obstructive sleep apnea syndrome.Integrating sleep management into clinical practice.Elevated fractalkine in patients with obstructive sleep apnea hypopnea syndrome.Obstructive sleep apnea and biomarkers of inflammation in ischemic stroke.
P2860
Q26768865-F58FB4B9-2132-468A-AB72-7654C0018D8CQ34288892-456A13E7-403A-4028-B437-A3BC517D26D9Q35769328-1D97D118-D9B5-4129-8E7E-EF89776D5A10Q36087909-CDFDD256-8587-43CB-A299-D2D460B9A6C4Q36117866-2E40960E-E5F4-47DA-B810-2764C4E4EE1BQ36322301-02B98CBA-5849-4C9D-8F64-9A6C079B24D7Q36537445-057BB55C-5580-4AC8-9569-A8F40D3E8D22Q38053459-13871FCB-A61F-4B71-AC57-2074868AE720Q38079601-65875643-E08E-487B-9D29-EBD58193801CQ38552168-1F37F6B8-FC67-4884-A7E2-A6884925EB09Q38831162-56B6F4C9-4B07-41A1-9673-2E4FB06D7276Q40038213-BF863777-1B23-4278-8D72-01A0166DECE1Q44558502-2850F986-9152-497A-AAD7-C45C4FDEAAD6Q45323315-24AF26D9-A483-4D90-B6CB-FAAEF6F35A03Q45344017-D560CCB1-8195-48A6-A629-7E60DBF5EEC9Q47655185-381653DB-F795-4BC9-AA70-F0FC3818EC52Q47718758-2F4BA34E-BE28-4134-8B49-78424684EB15Q47991108-0D9387E5-9A9D-40A2-9959-3974D47521B5Q47997854-2F0FFE96-1E7D-4610-B77D-FA6B0D016682Q48016701-8024406C-6641-4409-B1BD-BAC01AE60E46Q48033119-9463D8A2-9E09-4EBD-9219-89C720D3725FQ48093775-F746A103-7238-43D0-A91B-955C60EC9899Q48107296-9A31E3C1-457B-4AFB-A10F-26145241C8EEQ48213720-78870D08-26E0-4263-8427-7D0DE2F40C0BQ48224696-18B96A3A-48FA-40A8-AC7C-F559CA0EAE84Q48243754-EAAF15E7-4535-4CC4-A49D-F21A248A79D4Q48252660-48B234FC-F23A-4F02-AED1-3419C19AA9D2Q48255902-B07BDFEA-412F-4C70-A695-AB6B452483E1Q48283048-C0ABB90B-0C8D-48FA-94CB-F264A16BB120
P2860
Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inflammation accelerates ather ...... e sleep apnea syndrome (OSAS).
@en
Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome
@nl
type
label
Inflammation accelerates ather ...... e sleep apnea syndrome (OSAS).
@en
Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome
@nl
prefLabel
Inflammation accelerates ather ...... e sleep apnea syndrome (OSAS).
@en
Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome
@nl
P2860
P1433
P1476
Inflammation accelerates ather ...... e sleep apnea syndrome (OSAS).
@en
P2093
Alessandra Quercioli
François Mach
P2860
P2888
P304
P356
10.1007/S11325-010-0338-3
P577
2010-03-03T00:00:00Z